we provide the Basis for Your investment decision

At MSBC, we provide venture funds, private equity firms, and family offices with expert evaluation and strategic guidance for investments in the biotech sector. Our deep industry knowledge and hands-on experience in biotech make us the ideal partner for conducting thorough assessments of potential investments, ensuring you make informed decisions that align with your financial goals.

Comprehensive Investment Assessments
Investing in biotech companies and startups requires a detailed understanding of both scientific and business aspects. We specialize in conducting comprehensive evaluations of biotech opportunities, offering you a clear and in-depth analysis of the risks and potential rewards.

Our investment assessment services include:

• Strategic Fit Evaluation: We assess whether the target company or technology aligns with your investment strategy and portfolio objectives.


• Market Potential Analysis: Evaluate the competitive landscape, market demand, and growth potential for the target’s products or technologies, ensuring there’s a strong market opportunity.


• Business Model Viability: Review the company’s business model, commercialization strategy, and market access plan to determine the likelihood of long-term success.

Deep Development and Scientific Due Diligence
Biotech investments often hinge on the technical and clinical viability of the products in development. We offer deep scientific due diligence to ensure that the biotech companies you’re considering are on track for successful development.

Our development and technical assessments cover:

• CMC (Chemistry, Manufacturing, and Controls): We evaluate the company’s manufacturing processes, scalability, and regulatory compliance in relation to the product’s technical development.


• Clinical and Regulatory Review: Our experts assess the clinical development strategy, trial design, and regulatory pathway to determine whether the company can meet critical milestones.


• Pipeline and Portfolio Review: Analyze the strength of the company's product pipeline, examining each candidate's stage of development, differentiation, and commercial potential.

Financial and Management Team Evaluation
We provide a detailed assessment of the financial health and management capabilities of biotech companies, ensuring that they have the resources and leadership to succeed in a competitive environment.

• Financial Due Diligence: Review financial statements, funding history, burn rate, and revenue projections to assess the company’s financial stability and growth prospects.


• Management Team Assessment: Evaluate the experience and expertise of the leadership team, including their ability to navigate the scientific, operational, and commercial challenges of biotech.


• Exit Strategy and ROI Analysis: We analyze potential exit strategies and estimate return on investment (ROI), ensuring the deal structure and timelines meet your investment criteria.

Tailored Investment Recommendations
After conducting our in-depth assessments, we provide you with a clear, actionable recommendation. Our final reports include a comprehensive review of all findings and a clear assessment of risks, opportunities, and the company’s potential for success.

Our recommendations include:

• Risk Assessment and Mitigation Strategies: We identify key risks associated with the investment and provide strategic recommendations to mitigate them.


• Investment Structuring Advice: We offer guidance on structuring deals, including valuation considerations, equity stakes, and potential future rounds of financing.


• Ongoing Advisory Support: For investors looking for ongoing insights post-investment, we offer continued support, including advisory roles and interim management as needed.

Why Partner with MSBC?
With decades of experience in biosimilars and biotech, MSBC is uniquely positioned to provide investors with expert, unbiased assessments of biotech opportunities. Our rigorous evaluation process ensures you get a holistic view of both the scientific and business aspects of potential investments, empowering you to make well-informed decisions that maximize your returns while minimizing risks.
Partner with us to leverage our deep industry expertise and ensure your biotech investments are backed by solid data, strategic insights, and proven success in the field.